Ovarian Dysgerminomas: Multimedia

References

1. American College of Obstetrics and Gynecology. Educational bulletin: Ovarian Cancer. ACOG compendium of selected publications. No 250;2000:667-675.

2. Cotran RS, Kumar V, Robbins SL. Female genital tract. In: Robbins Pathologic Basis of Disease. Philadelphia, Pa: WB Saunders; 1996:1127-1180.

3. Disaia PJ, Creasman WT. Clinical Gynecologic Oncology. Mosby-Year Book; 1997:282-374.

4. Gershenson DM, Copeland LJ, del Junco G. Second-look laparotomy in the management of malignant germ cell tumors of the ovary. Obstet Gynecol. Jun 1986;67(6):789-93. [Medline].

5. Harvey RA, Champe PC, Mycek MJ. Anticancer drugs. In: Lippincott's Illustrated Reviews: Pharmacology. Baltimore, Md: Lippincott Williams & Wilkins; 1992:337-360.

6. Hoskins WJ, Perez CA, Young RC. Epithelial ovarian cancer. In: Principles and Practice of Gynecologic Oncology. Baltimore, Md: Lippincott Williams & Wilkins; 1992:715-781.

7. Isselbacher KJ, Braunwald E, Wilson JD. Principles of cancer therapy. In: Harrison's Principles of Internal Medicine. 13^th ed. New York, NY: McGraw-Hill; 1994:1826-1840.

8. Thompson JD, Rock JA. Surgical treatment of ovarian cancer. In: Telinde's Operative Gynecology. Baltimore, Md: Lippincott Williams & Wilkins; 1992:1303-1328.

Further Reading

Keywords

ovarian dysgerminomas, germ cell tumors, GCT, germinomas, malignant germ cell tumor, primitive germ cells, mixed germ cell tumor, dysgenic gonad, gonadoblastoma, epithelial ovarian tumors, sex cord tumors, metastatic Krukenberg tumors, sex cord stromal tumors, Sertoli-Leydig cell tumors, SLCT, malignant ovarian neoplasms, bilateral salpingo-oophorectomy, hysterectomy

Contributor Information and Disclosures

Author

Allan Y Wu, MD, Director, The Midwest Women's Specialty Group; Adjunct Clinical Professor, Department of Molecular Biology, The Terre Haute Center for Medical Education, Indiana University School of Medicine
Allan Y Wu, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists
Disclosure: Nothing to disclose.

Coauthor(s)

Chad M Michener, MD, Assistant Professor, Obstetrics/ Gynecology and Women's Health Institute, Section of Gynecologic Oncology, The Cleveland Clinic
Chad M Michener, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists and Society of Gynecologist Oncologists
Disclosure: Nothing to disclose.

Medical Editor

Gerard S Letterie, DO, Associate Clinical Professor, Medical Director of In-vitro Fertilization Lab, Department of Obstetrics and Gynecology, Virginia Mason Medical Center, University of Washington
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Michel E Rivlin, MD, Professor, Coordinator, Quality Assurance/Quality Improvement, Department of Obstetrics and Gynecology, University of Mississippi School of Medicine
Michel E Rivlin, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Mississippi State Medical Association, and Royal College of Surgeons of Edinburgh
Disclosure: Nothing to disclose.

CME Editor

Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Hancock Medical Center
Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians
Disclosure: Nothing to disclose.

Chief Editor

Michel E Rivlin, MD, Professor, Coordinator, Quality Assurance/Quality Improvement, Department of Obstetrics and Gynecology, University of Mississippi School of Medicine
Michel E Rivlin, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Mississippi State Medical Association, and Royal College of Surgeons of Edinburgh
Disclosure: Nothing to disclose.